Dissolution of gallstones with simvastatin, an HMG CoA reductase inhibitor

Digestive Diseases and Sciences

Volumn 43, Issue 2, 1998, Pages 349-353

  Chapman, B A ^a   Burt, M J ^a   Chisholm, R J ^a   Allan, R B ^a   Yeo, K H J ^a   Ross, A G ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Dissolution; Gallstones; HMG CoA reductase inhibitor; Simvastatin

Indexed keywords

ARACHIDONIC ACID; BILE ACID; CHOLECYSTOKININ OCTAPEPTIDE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; GALLBLADDER SCINTISCANNING; GALLSTONE; GALLSTONE DISSOLUTION; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; BILE ACIDS AND SALTS; CHOLELITHIASIS; CHOLESTEROL; DIABETES COMPLICATIONS; FATTY ACIDS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; SIMVASTATIN; TREATMENT OUTCOME;

EID: 0031893966     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018862507469     Document Type: Article

References (25)

1. Duane W, Hunninghake D, Freeman M, Pooler P, Schlasner L, Gebhard R: Simvastatin, a competitive inhibitor of HMG CoA reductase, lowers cholesterol saturation index of gallbladder bile. Hepatology 8:1147-1150, 1988
2. Logan G, Duane W: Lovastatin added to ursodeoxycholic acid further reduces biliary cholesterol saturation. Gastroenterology 98:1572-1576, 1990
3. Hoogerbrugge-VD LN, De Rooy F, Jansen H, Van Blankenstein M: Effect of pravastatin on biliary lipid composition and bile acid synthesis in familial hypercholesterolaemia. Gut 31:348-350, 1990
4. Wilson IR, Hurrell MA, Pattinson NR, Chapman BA: The effect of Simvastatin and bezafibrate on bile composition and gall-bladder emptying in female non-insulin-dependent diabetics. J Gastroenterol Hepatol 9:447-451, 1994
5. Okamoto S, Nakano K, Kosahara K, Kishinaka M, Oda H, Ichimiya H, Chijiiwa K, Kuroki S: Effect of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones. J Gastroenterol 29:47-55, 1994
6. Smit JWA, Van Erpecum KJ, Renooij W, Stolk MFJ, Edgar P, Doornewaard H, Vanberge-Henegouwen GP: The effect of 3-hydroxy-3-methyl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease. Hepatology 21:1523-1529, 1995
7. Holzbach R: Recent progress in understanding cholesterol crystal nucleation as a precursor to human gallstone formation. Hepatology 6:1403-1406, 1986
8. Schoenfield LJ, Lachin JM, Steering Committee (Baum RA, Habig RL, Hanson RF, Hersh Tr, Hightower NC Jr, Hofmann AF, Lasser EC, Marks JW, Mekhjian H, Okun R, Schaefer RA, Shaw L, Soloway RD, Thistle JL, Thomas FB, Tyor MP), National Cooperative Gallstone Study Group, Los Angeles, California and Bethesda, Maryland: Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: The National Cooperative Gallstone Study. A controlled trial of efficacy and safety. Ann Intern Med 95:257-282, 1981
9. Fromm H: Gallstone dissolution therapy: Current status and future prospects. Gastroenterology 91:1560-1567, 1986
10. Erlinger S, Co AL, Husson JM, Fevery J: Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones: A double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid. Hepatology 4:308-314, 1984
11. Bachrach WH, Hofmann AF: Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Dig Dis Sci 27:737-856, 1982
12. Smit JWA, Van Erpecum KJ, Stolk MFJ, Geerdink RA, Cluysenger OJJ, Erkelens DW, Van Berge-Henegouwen GP: Successful dissolution of cholesterol gallstone during treatment with pravastatin. Gastroenterology 103:1068-1070, 1992
13. Bazzoli F, Mazzella G, Zagori RM, Orsini M, Polimeni C, Novelli V, Fossi S, Morelli MC, Festi D, Aldini R, Roda A, Roda E: HMG CoA reductase inhibitors lower biliary cholesterol saturation but are ineffective cholesterol gallstone dissolving agents. Gastroenterology 102:A302, 1992
14. Bartlett GR: Phosphorus assay in column chromatography. J Biol Chem 234:466-468, 1959
15. Carey M: Critical tables for calculating the cholesterol saturation index of native bile. J Lipid Res 19:945-955, 1978
16. Bang HO, Dyerburg J, Sinclair HM: The composition of Eskimo food in northwestern Greenland. Am J Clin Nutri 33:2657-2661, 1980
17. Hernanz A, Codoceo R: An improved high performance liquid chromatography determination of conjugated bile acids in serum using paired-ion chromatography. Clin Chim Acta 145:197-203, 1985
18. Rossi SS, Converse JL, Hofmann AF: High pressure liquid chromatographic analysis of conjugate bile acids in human bile: Simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids. J Lipid Res 28:589-595, 1987
19. Dean PDG, Exley D, Johnson MW: Preparation of 17β-oestradiol-6-(O-carboxymethyl) oxime-bovine serum albumin. Steroids 18:593-603, 1971
20. Mazella G, Parini P, Festi D, Bazzoli F, Aldini R, Roda A, Tonelli D: Effect of simvastatin, ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolaemia. Hepatology 15:1072-1078, 1992
21. Loria P, Bertolotti M, Cassinadri MT, Dilengite MA, Bozzoli M, Carubbi F, Concari M: Short term effects of Simvastatin on bile acid synthesis and bile lipid secretion in human subjects. Hepatology 19:882-888, 1994
22. Muraca M, Baggio G, Miconi L, Vilei MT, Martini S, Gabelli C, Belluco C, Lise M, Crepaldi G: Acute effects of HMG-CoA reductase inhibitors on biliary lipids in patients with interrupted enterohepatic circulation. Eur J Clin Invest 21:204-208, 1991
23. La Morte WW, LaMont JT, Hale N, Booker ML, Scott TE, Turner B: Gallbladder prostoglandins and lysophospholipids as mediators of mucin secretion during cholelithiasis. Am J Physiol (Gastrointest Liver Physiol) 251:G701-G709, 1986
24. Cantafora A, Angelico M, DiBiase A: Structure of biliary phosphatidylcholine in cholesterol gallstone patients. Lipids 16:589-592, 1981
25. Marks JW, Bonorris GG, Albers G, Schoenfield LJ. The sequence of biliary events preceding the formation of gallstones in humans. Gastroenterology 103:566-570, 1992